| |
New Practice Strengthens ORC Pharma Offer
ORC International has launched a new practice within its Healthcare and Pharmaceutical division, focusing on FDA and Regulatory practice for the sector, and headed by Chief Research Officer Dr. Morris S. Whitcup.
Topics covered include FDA-related consumer and physician comprehension issues, Rx to OTC switches and Risk Evaluation and Mitigation Strategies (REMS).
Whitcup brings thirty years of experience in healthcare and pharmaceutical research, and is the author of numerous articles which have been published in industry journals as well as by units of the federal government.
ORC International, whose home page is at www.orcinternational.com , has offices across the USA, Europe and Asia Pacific and is part of Omaha, NE-based Infogroup, online at www.infogroup.com .
|
